Stryker Corporation (SYK)
NYSE • Healthcare
July 2, 2026 at 20:00 UTC
About Stryker Corporation
Stryker Corporation (NYSE: SYK) makes medical devices for orthopaedic, surgical, neurotechnology, and emergency-care settings. In healthcare, it sells implants for joint replacement procedures, trauma and extremity products, spinal systems, and hospital equipment, and it recorded $25.1 billion of revenue in FY2025.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
Stryker Corporation's Technical Indicators Summary
SYK around 326.54 shows constructive short-to-medium momentum with a positive MACD and strong short-term momentum, and the price trades above most short- and medium-term moving averages with the pivot comfortably below. ADX is low, so trend strength is limited, and volatility is moderate. On‑balance volume is negative despite price strength, which tempers the signal but does not erase multiple short-term bullish indicators. Technical takeaway: Buy — short- and medium-term momentum and moving-average alignment support a bullish bias.
| Indicator | Value |
|---|---|
RSI (14) | 57.98 |
Stochastic %K (14, 3, 3) | 53.62 |
CCI (20) | 95.31 |
WPR (14) | -23.09 |
Momentum (10) | 25.40 |
MFI | 72.53 |
MACD Level (12, 26) | 3.52 |
Bollinger Bands | $293.92 - $329.99 |
ATR (14) | $10.53 (3.23%) |
ADX (14) | 14.06 |
OBV | -26,899,212 |
Classic Pivot Point | $313.88 |
Fibonacci Pivot Point | $313.88 |
Simple Moving Averages | $309.05 - $347.52(5 indicators) |
Exponential Moving Averages | $314.20 - $344.52(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
The session wrapped with SYK still elevated after a strong 4.17% gap versus yesterday. By the final print, the sector’s 2.65% climb stood out as a meaningful tailwind. SYK extends gains after lawsuits against SYK were dismissed, with the broad sector rallying.
Trading Volume
0
vs S&P 500 Today
Strong Outperformance
+13.41%
52-Week Position
Mid-range
36.7%
Updated: July 2, 2026 at 20:06 UTC
Quote Summary
SYK Headlines
Citi Resets Life Sciences And MedTech Views
March 11, 2026
Quiet Compounders Lead 2025’s Year-End Market Tone
January 1, 2026